1Ness, AR & Powles, JW (1997) Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol 26, 1–13.
2Bravo, L (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317–333.
3Geleijnse, JM, Launer, LJ, Van der Kuip, DA, Hofman, A & Witteman, JC (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 75, 880–886.
4Hertog, M, Sweetnam, P, Fehily, AM, Elwood, PC & Kromhout, D (1997) Antioxidant flavonols and ischemic heart disease in Welsh population of men: the Caerphilly study. Am J Clin Nutr 65, 1489–1494.
5Hertog, MG, Feskens, EJ & Kromhout, D (1997) Antioxidant flavonols and coronary heart disease risk. Lancet 349, 699.
6Hertog, MGL, Feskens, EJM, Hollman, PCH, Katan, MB & Kromhout, D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342, 1007–1011.
7Knekt, P, Järvinen, R, Reunanen, A & Maatela, J (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 312, 478–481.
8Youchum, L, Kushi, LH, Meyer, K & Folsom, AR (1999) Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 149, 943–949.
9Hirvonen, T, Pietinen, P, Virtanen, MM-LO, Häkkinen, S, Albanes, D & Virtamo, J (2001) Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 12, 62–67.
10Arts, IC, Jacobs, DRJ, Harnack, LJ, Gross, M & Folsom, AR (2001) Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology 12, 668–675.
11Arts, IC, Hollman, PC, Feskens, EJ, Bueno de Mesquita, HB & Kromhout, D (2001) Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 74, 227–232.
12Knekt, P, Kumpulainen, J, Jarvinen, R, Rissanen, H, Heliovaara, M, Reunanen, A, Hakulinen, T & Aromaa, A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76, 560–568.
13Sesso, HD, Gaziano, JM, Liu, S & Buring, JE (2003) Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 77, 1400–1408.
14Rimm, E, Katan, M, Ascherio, A, Stampfer, MJ & Willet, WC (1996) Relation between intake of flavonoids and risk of coronary heart disease in male health professionals. Ann Intern Med 125, 384–389.
15Huxley, RR & Neil, HA (2003) The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr 57, 904–908.
16Mink, PJ, Scrafford, CG, Barraj, LM, Harnack, L, Hong, CP, Nettleton, JA & Jacobs, DRJ (2007) Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85, 895–909.
17Keli, SO, Hertog, MGL, Feskens, EJM & Kromhout, D (1996) Dietary flavonoids, antioxidant vitamins and incidence of stroke. Arch Intern Med 154, 637–642.
18Hirvonen, T, Virtamo, J, Korhonen, P, Albanes, D & Pietinen, P (2000) Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 31, 2301–2306.
19Dwyer, J & Peterson, JJ (2002) Measuring flavonoid intake: need for advanced tools. Public Health Nutr 5, 925–930.
21Salonen, JT (1988) Is there continuing need for longitudinal epidemiological research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20, 46–50.
22Lakka, TA, Laukkanen, JA, Rauramaa, R, Salonen, R, Lakka, H-M, Kaplan, GA & Salonen, JT (2001) Cardiorespiratory fitness and the progression of carotid atherosclerosis in middle-aged men. Ann Intern Med 134, 12–20.
23Tunstall-Pedoe, H, Kuulasmaa, K, Amouyel, p, Arveiler, D, Rajakangas, AM & Pajak, A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90, 583–612.
24Tuomilehto, J, Rastenyte, D, Sivenius, J, et al. (1996) Ten-year trends in stroke incidence and mortality in the FINMONICA Stroke Study. Stroke 27, 825–832.
25Kurl, S, Laukkanen, JA, Niskanen, L, Rauramaa, R, Tuomainen, TP, Sivenius, J & Salonen, JT (2005) Cardiac power during exercise and the risk of stroke in men. Stroke 36, 820–824.
26Willet, W & Stampfer, M (1998) . In Nutritional Epidemiology, pp. 273–301 [Willet, W, editor]. New York: Oxford University Press.
27Hodgson, JM, Burke, V & Puddey, IB (2005) Acute effects of tea on fasting and postprandial vascular function and blood pressure in humans. J Hypertens 23, 47–54.
28Vlachopoulos, C, Aznaouridis, K, Alexopoulos, N, Economou, E, Andreadou, I & Stefanadis, C (2005) Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 18, 785–791.
29Hayek, T, Furhman, B, Vaya, J, Rosenblat, M, Belinky, P, Coleman, R, Elis, A & Aviram, M (1997) Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation aggregation. Arterioscler Thromb Vasc Biol 17, 2744–2752.
30Fuhrman, B, Volkova, N, Coleman, R & Aviram, M (2005) Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J Nutr 135, 722–728.
31Williamson, G & Manach, C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81, 243–255.